HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pa-Thai Yenchitsomanus Selected Research

2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamine

1/2020Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells.
1/2018Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pa-Thai Yenchitsomanus Research Topics

Disease

26Infections
11/2021 - 05/2005
21Neoplasms (Cancer)
07/2022 - 10/2017
11Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
01/2017 - 01/2003
10Cholangiocarcinoma
01/2022 - 10/2017
8Breast Neoplasms (Breast Cancer)
03/2022 - 01/2018
7Dengue (Dengue Fever)
10/2021 - 05/2005
5Cytokine Release Syndrome
11/2021 - 06/2012
4Severe Dengue
08/2018 - 05/2005
3Triple Negative Breast Neoplasms
07/2022 - 12/2020
3Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2019
3Hepatocellular Carcinoma (Hepatoma)
11/2021 - 01/2017
3Virus Diseases (Viral Diseases)
11/2021 - 04/2006
3Type 2 Diabetes Mellitus (MODY)
07/2019 - 01/2011
3autosomal recessive distal Renal tubular acidosis
01/2019 - 01/2003
3Kidney Calculi (Kidney Stone)
07/2018 - 01/2012
3Thrombocytopenia (Thrombopenia)
01/2017 - 08/2014
3Acidosis
09/2012 - 04/2004
2Hyperglycemia
01/2021 - 01/2021
2Kidney Diseases (Kidney Disease)
10/2010 - 02/2006
1Multiple Myeloma
04/2022
1Bites and Stings (Sting)
01/2022
1Retinoblastoma (Glioblastoma, Retinal)
02/2021
1Overweight
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Carcinogenesis
12/2020

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2003
13Pharmaceutical PreparationsIBA
03/2022 - 01/2016
12dirhodium tetraacetate (DRTA)IBA
01/2019 - 01/2003
9AntigensIBA
04/2022 - 10/2017
9CytokinesIBA
06/2021 - 06/2012
9Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA
01/2019 - 01/2003
7Antiviral Agents (Antivirals)IBA
11/2021 - 01/2016
6Chimeric Antigen ReceptorsIBA
02/2021 - 01/2020
5Peptides (Polypeptides)IBA
11/2020 - 08/2014
5AnionsIBA
01/2017 - 09/2004
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2016
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2014
4Messenger RNA (mRNA)IBA
12/2020 - 02/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 - 01/2020
3VaccinesIBA
11/2021 - 11/2015
3ChemokinesIBA
06/2021 - 01/2016
3EnzymesIBA
12/2020 - 09/2008
3Interleukin-10 (Interleukin 10)IBA
10/2020 - 01/2016
3RNA (Ribonucleic Acid)IBA
03/2020 - 10/2017
3Viral RNAIBA
01/2020 - 02/2015
3Insulin (Novolin)FDA Link
07/2019 - 03/2002
3Transaminases (Aminotransferases)IBA
01/2017 - 08/2014
2LigandsIBA
01/2022 - 01/2018
2Folate Receptor 1IBA
01/2022 - 02/2021
2GemcitabineFDA Link
01/2022 - 01/2020
2SirtuinsIBA
11/2021 - 01/2019
2PolymersIBA
10/2021 - 01/2017
2cordycepinIBA
10/2021 - 05/2021
2mangostinIBA
06/2021 - 01/2017
2Viral Nonstructural ProteinsIBA
01/2021 - 01/2020
2Transcription Factors (Transcription Factor)IBA
01/2020 - 08/2012
22- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA
01/2020 - 01/2018
2Neoplasm Antigens (Tumor Antigens)IBA
11/2019 - 10/2017
23' Untranslated Regions (3' UTR)IBA
01/2019 - 04/2018
2MorpholinosIBA
01/2019 - 04/2018
2Coat Protein Complex I (COPI)IBA
01/2018 - 01/2017
2Bicarbonates (Hydrogen Carbonate)IBA
01/2017 - 09/2004
2ChloridesIBA
01/2017 - 09/2004
2DNA (Deoxyribonucleic Acid)IBA
05/2014 - 08/2002
2Hemoglobins (Hemoglobin)IBA
07/2009 - 06/2007
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
07/2022
1Ribosomal Proteins (Ribosomal Protein)IBA
07/2022
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
04/2022
1B-Cell Maturation AntigenIBA
04/2022
1fas Receptor (CD95 Antigen)IBA
03/2022
1NucleolinIBA
01/2022
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2022
1Interleukin-4 (Interleukin 4)IBA
01/2022
1atezolizumabIBA
01/2022
1Interleukin-1 (Interleukin 1)IBA
01/2022
1Biological ProductsIBA
12/2021
1Gallic AcidIBA
11/2021
1triphalaIBA
11/2021
1MelatoninIBA
11/2021
1Hormones (Hormone)IBA
11/2021
1InterferonsIBA
11/2021
1GraphiteIBA
10/2021
1IntegrinsIBA
01/2021
1Single-Chain AntibodiesIBA
01/2021
1Antigen Receptors (Antigen Receptor)IBA
01/2021
1GlucocorticoidsIBA
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2021
1Mucin-1 (CA 15-3 Antigen)IBA
01/2021
1SteroidsIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Estrogen ReceptorsIBA
12/2020
1Protein Disulfide-IsomerasesIBA
12/2020
1Adenosine Triphosphate (ATP)IBA
12/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2020
1Interleukin-10 ReceptorsIBA
10/2020

Therapy/Procedure

13Therapeutics
04/2022 - 06/2007
7Immunotherapy
03/2022 - 10/2017
4Drug Therapy (Chemotherapy)
03/2022 - 01/2019
1Ayurvedic Medicine (Siddha Medicine)
11/2021